Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either trans...
Uložené v:
| Vydané v: | Cell reports (Cambridge) Ročník 16; číslo 3; s. 631 - 643 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Elsevier Inc
19.07.2016
Cell Press Elsevier |
| Predmet: | |
| ISSN: | 2211-1247, 2211-1247 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting.
[Display omitted]
•NFIB drives tumor initiation and progression in mouse models of SCLC•NFIB enhances metastasis and changes the metastatic profile•NFIB promotes dedifferentiation and invasion in SCLC•NFIB marks stage III/IV high-grade neuroendocrine carcinomas in patients
SCLC is a highly malignant cancer with an unmet need for better intervention strategies. Semenova et al. report that the transcription factor NFIB drives SCLC growth and metastasis, defines an aggressive tumor compartment in mice, and marks a subgroup of high-grade pulmonary neuroendocrine tumors (pNETs) in patients. |
|---|---|
| AbstractList | Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting. Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting.Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting. Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting. • NFIB drives tumor initiation and progression in mouse models of SCLC • NFIB enhances metastasis and changes the metastatic profile • NFIB promotes dedifferentiation and invasion in SCLC • NFIB marks stage III/IV high-grade neuroendocrine carcinomas in patients SCLC is a highly malignant cancer with an unmet need for better intervention strategies. Semenova et al. report that the transcription factor NFIB drives SCLC growth and metastasis, defines an aggressive tumor compartment in mice, and marks a subgroup of high-grade pulmonary neuroendocrine tumors (pNETs) in patients. Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the inactivation of Rb1 and Trp53 show frequent amplifications of the Nfib and Mycl genes. Here, we report that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread. High NFIB levels are associated with expansive growth of a poorly differentiated and almost exclusively E-cadherin (CDH1)-negative invasive tumor cell population. Consistent with the mouse data, we find that NFIB is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors, warranting further assessment of NFIB as a tumor progression marker in a clinical setting. [Display omitted] •NFIB drives tumor initiation and progression in mouse models of SCLC•NFIB enhances metastasis and changes the metastatic profile•NFIB promotes dedifferentiation and invasion in SCLC•NFIB marks stage III/IV high-grade neuroendocrine carcinomas in patients SCLC is a highly malignant cancer with an unmet need for better intervention strategies. Semenova et al. report that the transcription factor NFIB drives SCLC growth and metastasis, defines an aggressive tumor compartment in mice, and marks a subgroup of high-grade pulmonary neuroendocrine tumors (pNETs) in patients. |
| Author | Pritchard, Colin Berns, Anton Proost, Natalie Krijgsman, Oscar Zevenhoven, John Bhaskaran, Rajith Velds, Arno Kuilman, Thomas Peters, Dennis Cozijnsen, Miranda Kwon, Min-chul Song, Ji-Ying Smit, Egbert F. Lambooij, Jan-Paul van der Vliet, Jan Buikhuisen, Wieneke A. Huijbers, Ivo J. Monkhorst, Kim Semenova, Ekaterina A. van Montfort, Erwin |
| AuthorAffiliation | 3 Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands 6 Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands 9 Skolkovo Institute of Science and Technology, Moscow 143026, Russia 1 Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands 7 Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands 4 Core Facility for Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands 2 Division of Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands 5 Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands 8 Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands |
| AuthorAffiliation_xml | – name: 2 Division of Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – name: 7 Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – name: 1 Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – name: 4 Core Facility for Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – name: 5 Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – name: 8 Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – name: 9 Skolkovo Institute of Science and Technology, Moscow 143026, Russia – name: 3 Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – name: 6 Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands |
| Author_xml | – sequence: 1 givenname: Ekaterina A. surname: Semenova fullname: Semenova, Ekaterina A. organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 2 givenname: Min-chul surname: Kwon fullname: Kwon, Min-chul organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 3 givenname: Kim surname: Monkhorst fullname: Monkhorst, Kim organization: Division of Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 4 givenname: Ji-Ying surname: Song fullname: Song, Ji-Ying organization: Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 5 givenname: Rajith surname: Bhaskaran fullname: Bhaskaran, Rajith organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 6 givenname: Oscar surname: Krijgsman fullname: Krijgsman, Oscar organization: Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 7 givenname: Thomas surname: Kuilman fullname: Kuilman, Thomas organization: Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 8 givenname: Dennis surname: Peters fullname: Peters, Dennis organization: Core Facility for Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 9 givenname: Wieneke A. surname: Buikhuisen fullname: Buikhuisen, Wieneke A. organization: Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 10 givenname: Egbert F. surname: Smit fullname: Smit, Egbert F. organization: Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 11 givenname: Colin surname: Pritchard fullname: Pritchard, Colin organization: Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 12 givenname: Miranda surname: Cozijnsen fullname: Cozijnsen, Miranda organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 13 givenname: Jan surname: van der Vliet fullname: van der Vliet, Jan organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 14 givenname: John surname: Zevenhoven fullname: Zevenhoven, John organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 15 givenname: Jan-Paul surname: Lambooij fullname: Lambooij, Jan-Paul organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 16 givenname: Natalie surname: Proost fullname: Proost, Natalie organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 17 givenname: Erwin surname: van Montfort fullname: van Montfort, Erwin organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 18 givenname: Arno surname: Velds fullname: Velds, Arno organization: Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 19 givenname: Ivo J. surname: Huijbers fullname: Huijbers, Ivo J. email: i.huijbers@nki.nl organization: Mouse Clinic for Cancer and Aging research Transgenic Core Facility, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands – sequence: 20 givenname: Anton surname: Berns fullname: Berns, Anton email: a.berns@nki.nl organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27373156$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUsFuEzEQXaEiWkr_ACEfuSTYXtub5YAEKYFICVSinK1ZezY4bOzU3kRC6sfXS1LUcgBr5LE9895Y8-Z5ceKDx6J4yeiYUaberMcGu4jbMc-3Mc3G6ZPijHPGRoyL6uTB-bS4SGlN81KUsVo8K055VVYlk-qsuL2O4JOJbtu74MkMTB8i-TKbfyDzRIBcRrfHSEJLvm2g68gU87bY-RWZgjc5chXDKmJKA9p5snQGCXhLlhB_JrLEHlIPvTPk0iWEhEPSVX5A36cXxdMWuoQXR39efJ99vJ5-Hi2-fppP3y9GRtayH4mmsWXdgORY17W1qqnqCcPKVpxSIyZCWIOGtkxmJ3LU1LaxAMK2lLKqKc-L-YHXBljrbXQbiL90AKd_P4S40hDzHzvU1EgUjbSAjAnDy0mpaguTRiJV0LYsc707cG13zQZzYd9H6B6RPo5490Ovwl6LWirFqkzw-kgQw80OU683LmU1O_AYdkmzCVWiVJLxnPrqYa0_Re7lywlvDwkmhpQittq4odthKO06zagexkWv9WFc9DAummbjNIPFX-B7_v_Ajg3ArNjeYdTJZDUNWhfR9Lml7t8Ed8ft3OA |
| CitedBy_id | crossref_primary_10_1016_j_jgg_2020_07_001 crossref_primary_10_1038_s12276_019_0349_5 crossref_primary_10_1038_s41467_019_13295_y crossref_primary_10_1038_s41467_023_40846_1 crossref_primary_10_1007_s10529_017_2428_9 crossref_primary_10_1016_j_jtho_2020_01_016 crossref_primary_10_1016_j_neuron_2025_08_003 crossref_primary_10_3390_ijms21144934 crossref_primary_10_1016_j_ccell_2021_06_016 crossref_primary_10_1177_1533033819874802 crossref_primary_10_1101_gad_338228_120 crossref_primary_10_1016_j_jtho_2024_03_023 crossref_primary_10_1016_j_omto_2019_12_009 crossref_primary_10_1111_pcmr_12710 crossref_primary_10_1038_s43018_022_00361_6 crossref_primary_10_3390_cancers17020255 crossref_primary_10_1158_1541_7786_MCR_23_0002 crossref_primary_10_1038_s41388_021_02070_3 crossref_primary_10_1016_j_semcancer_2020_11_006 crossref_primary_10_1016_j_ebiom_2017_05_027 crossref_primary_10_1080_15384101_2019_1578145 crossref_primary_10_1002_1878_0261_12608 crossref_primary_10_1016_j_jddst_2024_105933 crossref_primary_10_1111_apm_12828 crossref_primary_10_1158_2159_8290_CD_18_0385 crossref_primary_10_7554_eLife_50616 crossref_primary_10_1016_j_jgg_2021_05_007 crossref_primary_10_1093_brain_awae366 crossref_primary_10_1038_s41556_023_01241_6 crossref_primary_10_15252_emmm_202013162 crossref_primary_10_1002_path_5109 crossref_primary_10_3390_cancers16183152 crossref_primary_10_3390_cancers13010014 crossref_primary_10_1038_s41467_023_35864_y crossref_primary_10_1158_2159_8290_CD_17_0987 crossref_primary_10_1016_j_biopha_2021_111450 crossref_primary_10_1146_annurev_cancerbio_030419_033413 crossref_primary_10_1186_s12943_024_01953_9 crossref_primary_10_1002_path_5182 crossref_primary_10_3389_fonc_2023_1075385 crossref_primary_10_1007_s10555_024_10220_8 crossref_primary_10_1038_s41568_025_00803_0 crossref_primary_10_1080_14728222_2020_1732353 crossref_primary_10_3389_fonc_2024_1509183 crossref_primary_10_1016_j_jbc_2023_105193 crossref_primary_10_1038_nrclinonc_2016_203 crossref_primary_10_1038_s41388_025_03481_2 crossref_primary_10_1038_s43018_019_0020_z crossref_primary_10_1016_j_jtho_2022_11_019 crossref_primary_10_1007_s13721_018_0173_1 crossref_primary_10_1177_00368504251345012 crossref_primary_10_1002_1878_0261_12829 crossref_primary_10_1016_j_jhep_2017_06_007 crossref_primary_10_1073_pnas_1821893117 crossref_primary_10_3390_ijms20246296 crossref_primary_10_1038_s41467_025_60141_5 crossref_primary_10_1080_15384101_2017_1339849 crossref_primary_10_1111_1759_7714_14574 crossref_primary_10_1158_0008_5472_CAN_23_1079 crossref_primary_10_1007_s12038_019_9903_5 crossref_primary_10_3322_caac_21785 crossref_primary_10_1016_j_jtho_2017_02_008 crossref_primary_10_1158_2159_8290_CD_22_0620 crossref_primary_10_1038_s41388_023_02929_7 crossref_primary_10_1186_s40164_024_00548_w crossref_primary_10_1111_his_15040 crossref_primary_10_1177_2398212817739433 crossref_primary_10_1016_j_jbc_2023_105124 crossref_primary_10_1038_s41467_023_39291_x crossref_primary_10_3390_ijms22010027 crossref_primary_10_1038_s12276_022_00905_x crossref_primary_10_1158_2159_8290_CD_21_0441 crossref_primary_10_1016_j_jtho_2018_02_002 crossref_primary_10_1038_s41416_022_02103_y crossref_primary_10_1016_j_celrep_2025_115603 crossref_primary_10_1158_1541_7786_MCR_20_1006 crossref_primary_10_1111_cas_15481 crossref_primary_10_1038_s41379_018_0005_y crossref_primary_10_1186_s40478_021_01299_z crossref_primary_10_1158_1541_7786_MCR_24_0265 crossref_primary_10_15252_emmm_202013122 crossref_primary_10_1101_gad_349359_122 crossref_primary_10_3390_genes9010012 crossref_primary_10_1016_j_prp_2020_153236 crossref_primary_10_1038_s41572_020_00235_0 crossref_primary_10_1002_cam4_1434 crossref_primary_10_2478_fco_2019_0010 crossref_primary_10_1177_1708538117736695 crossref_primary_10_1093_nsr_nwab232 crossref_primary_10_1016_j_ccell_2016_12_005 crossref_primary_10_1002_cnr2_70018 crossref_primary_10_1016_j_humpath_2018_05_009 crossref_primary_10_1007_s10555_020_09931_5 crossref_primary_10_1038_nrendo_2017_16 crossref_primary_10_3390_cancers10080248 crossref_primary_10_1016_j_ebiom_2017_01_013 crossref_primary_10_1038_s41587_023_01737_4 crossref_primary_10_3389_fcell_2022_825272 crossref_primary_10_1038_nrc_2017_87 crossref_primary_10_1038_s43018_020_0046_2 crossref_primary_10_1109_TCBB_2018_2820695 crossref_primary_10_1002_ijc_30603 crossref_primary_10_3390_ijms25052479 crossref_primary_10_1016_j_lungcan_2020_05_012 crossref_primary_10_1038_s41568_024_00744_0 crossref_primary_10_1016_j_canlet_2017_09_015 crossref_primary_10_1038_s41368_023_00243_2 crossref_primary_10_1016_j_bbagrm_2022_194798 |
| Cites_doi | 10.1002/jor.22873 10.1038/nature14664 10.1016/j.cell.2014.02.031 10.1097/JTO.0000000000000459 10.1074/jbc.272.16.10739 10.1002/bies.201400141 10.1101/gad.2046711 10.1038/ng.2405 10.1101/gad.262998.115 10.4297/najms.2011.3227 10.1016/S0378-1119(00)00140-2 10.1097/JTO.0000000000000630 10.3892/or.2016.4621 10.1016/0092-8674(89)90108-6 10.3892/or.2015.3715 10.1111/j.1349-7006.2001.tb01112.x 10.1016/j.molonc.2011.01.006 10.1186/s13059-015-0617-1 10.18632/oncotarget.7047 10.1523/JNEUROSCI.2319-13.2014 10.1242/bio.20147765 10.1002/emmm.201303297 10.1016/j.molonc.2013.02.010 10.1002/gcc.22076 10.1016/j.mcn.2006.10.008 10.1002/gcc.20550 10.1016/S1535-6108(03)00220-4 10.1016/j.cell.2010.11.055 10.1016/j.semcancer.2012.02.012 10.1016/j.ydbio.2011.04.002 10.1101/gad.263145.115 10.1158/0008-5472.CAN-13-3602 10.1016/j.stem.2013.07.002 10.1152/ajplung.00356.2014 10.1038/nprot.2015.114 10.1073/pnas.1410419111 10.1002/cncr.29098 10.1128/MCB.25.2.685-698.2005 10.1002/dvdy.24182 10.1016/j.ccr.2010.12.021 10.1038/nature11847 10.1038/modpathol.2011.150 |
| ContentType | Journal Article |
| Copyright | 2016 The Author(s) Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved. 2016 The Author(s) 2016 |
| Copyright_xml | – notice: 2016 The Author(s) – notice: Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved. – notice: 2016 The Author(s) 2016 |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1016/j.celrep.2016.06.020 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2211-1247 |
| EndPage | 643 |
| ExternalDocumentID | oai_doaj_org_article_0c5e4b5dae114c238369da8b5e06aff1 PMC4956617 27373156 10_1016_j_celrep_2016_06_020 S2211124716307604 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 0SF 4.4 457 53G 5VS 6I. AACTN AAEDT AAEDW AAFTH AAIKJ AAKRW AALRI AAUCE AAXJY AAXUO ABMAC ABMWF ACGFO ACGFS ADBBV ADEZE AENEX AEXQZ AFTJW AGHFR AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BCNDV DIK EBS EJD FCP FDB FRP GROUPED_DOAJ GX1 IPNFZ IXB KQ8 M41 M48 NCXOZ O-L O9- OK1 RCE RIG ROL SSZ AAMRU AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AIGII AKBMS AKRWK AKYEP APXCP CITATION HZ~ CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c595t-4bbd39ba52e999dd6b7981e7d7200c4844dcec0f15cec46b7c9dbdaa4df0017b3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 120 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000380264200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2211-1247 |
| IngestDate | Fri Oct 03 12:53:34 EDT 2025 Tue Sep 30 16:33:57 EDT 2025 Thu Jul 10 17:11:25 EDT 2025 Thu Apr 03 07:10:04 EDT 2025 Wed Nov 05 20:35:13 EST 2025 Tue Nov 18 21:46:56 EST 2025 Wed May 17 01:06:23 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c595t-4bbd39ba52e999dd6b7981e7d7200c4844dcec0f15cec46b7c9dbdaa4df0017b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Co-senior author Co-first author |
| OpenAccessLink | https://doaj.org/article/0c5e4b5dae114c238369da8b5e06aff1 |
| PMID | 27373156 |
| PQID | 1806436512 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0c5e4b5dae114c238369da8b5e06aff1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4956617 proquest_miscellaneous_1806436512 pubmed_primary_27373156 crossref_citationtrail_10_1016_j_celrep_2016_06_020 crossref_primary_10_1016_j_celrep_2016_06_020 elsevier_sciencedirect_doi_10_1016_j_celrep_2016_06_020 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-07-19 |
| PublicationDateYYYYMMDD | 2016-07-19 |
| PublicationDate_xml | – month: 07 year: 2016 text: 2016-07-19 day: 19 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cell reports (Cambridge) |
| PublicationTitleAlternate | Cell Rep |
| PublicationYear | 2016 |
| Publisher | Elsevier Inc Cell Press Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Cell Press – name: Elsevier |
| References | Rudin, Durinck, Stawiski, Poirier, Modrusan, Shames, Bergbower, Guan, Shin, Guillory (bib32) 2012; 44 Harris, Genovesi, Gronostajski, Wainwright, Piper (bib15) 2015; 244 Gazdar, Savage, Johnson, Berns, Sage, Linnoila, MacPherson, McFadden, Farago, Jacks (bib10) 2015; 10 Holm, Mader, Haubst, Wizenmann, Sigvardsson, Götz (bib16) 2007; 34 Chang, Pasolli, Giannopoulou, Guasch, Gronostajski, Elemento, Fuchs (bib6) 2013; 495 Semenova, Nagel, Berns (bib34) 2015; 29 Ninkovic, Steiner-Mezzadri, Jawerka, Akinci, Masserdotti, Petricca, Fischer, von Holst, Beckers, Lie (bib29) 2013; 13 Augustyn, Borromeo, Wang, Fujimoto, Shao, Dospoy, Lee, Tan, Sullivan, Larsen (bib2) 2014; 111 Dooley, Winslow, Chiang, Banerji, Stransky, Dayton, Snyder, Senna, Whittaker, Bronson (bib7) 2011; 25 George, Lim, Jang, Cun, Ozretić, Kong, Leenders, Lu, Fernández-Cuesta, Bosco (bib11) 2015; 524 Calbo, van Montfort, Proost, van Drunen, Beverloo, Meuwissen, Berns (bib4) 2011; 19 Ghanem, Fabrice (bib12) 2011; 5 Han, Jung, Cho, Lee, Hwang, Yang, Kang, Bae, Jeon, Park (bib14) 2008; 47 Byers, Rudin (bib3) 2015; 121 Mermod, O’Neill, Kelly, Tjian (bib26) 1989; 58 Stephens, Greenman, Fu, Yang, Bignell, Mudie, Pleasance, Lau, Beare, Stebbings (bib37) 2011; 144 French, Johnatty, Lu, Beesley, Gao, Kalimutho, Henderson, Russell, Kar, Chen (bib9) 2016; 7 Hsu, Osinski, Campbell, Litwack, Wang, Liu, Bachurski, Gronostajski (bib17) 2011; 354 Zhang, Cao, Cheng, Zhang, Jin, Li (bib43) 2015; 33 Iwakawa, Takenaka, Kohno, Shimada, Totoki, Shibata, Tsuta, Nishikawa, Noguchi, Sato-Otsubo (bib20) 2013; 52 Meuwissen, Linn, Linnoila, Zevenhoven, Mooi, Berns (bib27) 2003; 4 Yang, Imoto, Pimkhaokham, Shimada, Sasaki, Oka, Inazawa (bib42) 2001; 92 Kwon, Berns (bib22) 2013; 7 Travis, Brambilla, Nicholson, Yatabe, Austin, Beasley, Chirieac, Dacic, Duhig, Flieder (bib39) 2015; 10 Huijbers, Bin Ali, Pritchard, Cozijnsen, Kwon, Proost, Song, de Vries, Badhai, Sutherland (bib18) 2014; 6 Wang, Huang, Chintagari, Xi, Weng, Liu (bib41) 2015; 309 Piper, Barry, Harvey, McLeay, Smith, Harris, Mason, Stringer, Day, Wray (bib30) 2014; 34 Kuilman, Velds, Kemper, Ranzani, Bombardelli, Hoogstraat, Nevedomskaya, Xu, de Ruiter, Lolkema (bib21) 2015; 16 Singhai, Patil, Jaiswal, Patil, Tayade, Patil (bib35) 2011; 3 McFadden, Papagiannakopoulos, Taylor-Weiner, Stewart, Carter, Cibulskis, Bhutkar, McKenna, Dooley, Vernon (bib25) 2014; 156 Tsai, Bake, Balaraman, Rawlings, Holgate, Dubois, Miranda (bib40) 2014; 3 Huijbers, Del Bravo, Bin Ali, Pritchard, Braumuller, van Miltenburg, Henneman, Michalak, Berns, Jonkers (bib19) 2015; 10 Quattrini, Pollino, Pazzaglia, Conti, Novello, Ferrari, Pignotti, Picci, Benassi (bib31) 2015; 33 Cermáková, Tesina, Demeulemeester, El Ashkar, Méreau, Schwaller, Rezáčová, Veverka, De Rijck (bib5) 2014; 74 Gronostajski (bib13) 2000; 249 Andreasen, Persson, Kiss, Homøe, Heegaard, Stenman (bib1) 2016; 35 Travis (bib38) 2012; 25 Steele-Perkins, Plachez, Butz, Yang, Bachurski, Kinsman, Litwack, Richards, Gronostajski (bib36) 2005; 25 Liu, Bernard, Apt (bib24) 1997; 272 Schneider, Kolligs (bib33) 2015; 37 Mosakhani, Pazzaglia, Benassi, Borze, Quattrini, Picci, Knuutila (bib28) 2013; 28 Ellenbroek, Iden, Collard (bib8) 2012; 22 Kwon, Proost, Song, Sutherland, Zevenhoven, Berns (bib23) 2015; 29 Holm (10.1016/j.celrep.2016.06.020_bib16) 2007; 34 Kuilman (10.1016/j.celrep.2016.06.020_bib21) 2015; 16 Rudin (10.1016/j.celrep.2016.06.020_bib32) 2012; 44 Harris (10.1016/j.celrep.2016.06.020_bib15) 2015; 244 Singhai (10.1016/j.celrep.2016.06.020_bib35) 2011; 3 Meuwissen (10.1016/j.celrep.2016.06.020_bib27) 2003; 4 Quattrini (10.1016/j.celrep.2016.06.020_bib31) 2015; 33 George (10.1016/j.celrep.2016.06.020_bib11) 2015; 524 Augustyn (10.1016/j.celrep.2016.06.020_bib2) 2014; 111 Ellenbroek (10.1016/j.celrep.2016.06.020_bib8) 2012; 22 Piper (10.1016/j.celrep.2016.06.020_bib30) 2014; 34 Chang (10.1016/j.celrep.2016.06.020_bib6) 2013; 495 Kwon (10.1016/j.celrep.2016.06.020_bib22) 2013; 7 Andreasen (10.1016/j.celrep.2016.06.020_bib1) 2016; 35 Han (10.1016/j.celrep.2016.06.020_bib14) 2008; 47 Ghanem (10.1016/j.celrep.2016.06.020_bib12) 2011; 5 Liu (10.1016/j.celrep.2016.06.020_bib24) 1997; 272 McFadden (10.1016/j.celrep.2016.06.020_bib25) 2014; 156 Dooley (10.1016/j.celrep.2016.06.020_bib7) 2011; 25 Huijbers (10.1016/j.celrep.2016.06.020_bib19) 2015; 10 Hsu (10.1016/j.celrep.2016.06.020_bib17) 2011; 354 Schneider (10.1016/j.celrep.2016.06.020_bib33) 2015; 37 Byers (10.1016/j.celrep.2016.06.020_bib3) 2015; 121 Semenova (10.1016/j.celrep.2016.06.020_bib34) 2015; 29 Iwakawa (10.1016/j.celrep.2016.06.020_bib20) 2013; 52 Steele-Perkins (10.1016/j.celrep.2016.06.020_bib36) 2005; 25 Travis (10.1016/j.celrep.2016.06.020_bib38) 2012; 25 Yang (10.1016/j.celrep.2016.06.020_bib42) 2001; 92 Kwon (10.1016/j.celrep.2016.06.020_bib23) 2015; 29 French (10.1016/j.celrep.2016.06.020_bib9) 2016; 7 Stephens (10.1016/j.celrep.2016.06.020_bib37) 2011; 144 Huijbers (10.1016/j.celrep.2016.06.020_bib18) 2014; 6 Mosakhani (10.1016/j.celrep.2016.06.020_bib28) 2013; 28 Travis (10.1016/j.celrep.2016.06.020_bib39) 2015; 10 Cermáková (10.1016/j.celrep.2016.06.020_bib5) 2014; 74 Zhang (10.1016/j.celrep.2016.06.020_bib43) 2015; 33 Mermod (10.1016/j.celrep.2016.06.020_bib26) 1989; 58 Wang (10.1016/j.celrep.2016.06.020_bib41) 2015; 309 Calbo (10.1016/j.celrep.2016.06.020_bib4) 2011; 19 Gronostajski (10.1016/j.celrep.2016.06.020_bib13) 2000; 249 Gazdar (10.1016/j.celrep.2016.06.020_bib10) 2015; 10 Ninkovic (10.1016/j.celrep.2016.06.020_bib29) 2013; 13 Tsai (10.1016/j.celrep.2016.06.020_bib40) 2014; 3 11346465 - Jpn J Cancer Res. 2001 Apr;92(4):423-8 21764851 - Genes Dev. 2011 Jul 15;25(14):1470-5 23389444 - Nature. 2013 Mar 7;495(7439):98-102 22214967 - Mod Pathol. 2012 Jan;25 Suppl 1:S18-30 24630729 - Cell. 2014 Mar 13;156(6):1298-311 23172052 - Histol Histopathol. 2013 May;28(5):671-8 26492136 - Nat Protoc. 2015 Nov;10(11):1755-85 26220992 - Genes Dev. 2015 Jul 15;29(14):1447-62 25887352 - Genome Biol. 2015 Feb 27;16:49 24401838 - EMBO Mol Med. 2014 Feb;6(2):212-25 23933087 - Cell Stem Cell. 2013 Oct 3;13(4):403-18 26883388 - Oncol Rep. 2016 Apr;35(4):2177-82 21215367 - Cell. 2011 Jan 7;144(1):27-40 25764026 - J Orthop Res. 2015 Aug;33(8):1205-11 23716474 - Genes Chromosomes Cancer. 2013 Sep;52(9):802-16 26291008 - J Thorac Oncol. 2015 Sep;10(9):1243-60 23481268 - Mol Oncol. 2013 Apr;7(2):165-77 21316603 - Cancer Cell. 2011 Feb 15;19(2):244-56 26840454 - Oncotarget. 2016 Feb 9;7(6):6353-68 25267614 - Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14788-93 28449525 - J Thorac Dis. 2017 Mar;9(3):E295-E296 15632069 - Mol Cell Biol. 2005 Jan;25(2):685-98 14522252 - Cancer Cell. 2003 Sep;4(3):181-9 21324755 - Mol Oncol. 2011 Apr;5(2):150-5 25063196 - Biol Open. 2014 Jul 25;3(8):741-58 22558599 - N Am J Med Sci. 2011 May;3(5):227-33 25082813 - Cancer Res. 2014 Sep 15;74(18):5139-51 17158062 - Mol Cell Neurosci. 2007 Jan;34(1):99-119 24553933 - J Neurosci. 2014 Feb 19;34(8):2921-30 26215568 - Genes Dev. 2015 Aug 1;29(15):1587-92 25336398 - Cancer. 2015 Mar 1;121(5):664-72 25675280 - J Thorac Oncol. 2015 Apr;10(4):553-64 25591821 - Oncol Rep. 2015 Mar;33(3):1335-41 21513708 - Dev Biol. 2011 Jun 15;354(2):242-52 9099724 - J Biol Chem. 1997 Apr 18;272(16):10739-45 22465739 - Semin Cancer Biol. 2012 Jun;22(3):208-15 22941189 - Nat Genet. 2012 Oct;44(10):1111-6 26071557 - Am J Physiol Lung Cell Mol Physiol. 2015 Aug 15;309(4):L400-13 26168399 - Nature. 2015 Aug 6;524(7563):47-53 2504497 - Cell. 1989 Aug 25;58(4):741-53 25449798 - Bioessays. 2015 Mar;37(3):294-304 25156673 - Dev Dyn. 2015 Mar;244(3):227-38 18314908 - Genes Chromosomes Cancer. 2008 Jun;47(6):490-9 10831836 - Gene. 2000 May 16;249(1-2):31-45 |
| References_xml | – volume: 74 start-page: 5139 year: 2014 end-page: 5151 ident: bib5 article-title: Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia publication-title: Cancer Res. – volume: 10 start-page: 1243 year: 2015 end-page: 1260 ident: bib39 article-title: The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification publication-title: J. Thorac. Oncol. – volume: 272 start-page: 10739 year: 1997 end-page: 10745 ident: bib24 article-title: NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing publication-title: J. Biol. Chem. – volume: 3 start-page: 741 year: 2014 end-page: 758 ident: bib40 article-title: MiR-153 targets the nuclear factor-1 family and protects against teratogenic effects of ethanol exposure in fetal neural stem cells publication-title: Biol. Open – volume: 29 start-page: 1447 year: 2015 end-page: 1462 ident: bib34 article-title: Origins, genetic landscape, and emerging therapies of small cell lung cancer publication-title: Genes Dev. – volume: 6 start-page: 212 year: 2014 end-page: 225 ident: bib18 article-title: Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells publication-title: EMBO Mol. Med. – volume: 28 start-page: 671 year: 2013 end-page: 678 ident: bib28 article-title: MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone publication-title: Histol. Histopathol. – volume: 34 start-page: 2921 year: 2014 end-page: 2930 ident: bib30 article-title: NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development publication-title: J. Neurosci. – volume: 249 start-page: 31 year: 2000 end-page: 45 ident: bib13 article-title: Roles of the NFI/CTF gene family in transcription and development publication-title: Gene – volume: 7 start-page: 165 year: 2013 end-page: 177 ident: bib22 article-title: Mouse models for lung cancer publication-title: Mol. Oncol. – volume: 244 start-page: 227 year: 2015 end-page: 238 ident: bib15 article-title: Nuclear factor one transcription factors: divergent functions in developmental versus adult stem cell populations publication-title: Dev. Dyn. – volume: 309 start-page: L400 year: 2015 end-page: L413 ident: bib41 article-title: miR-124 regulates fetal pulmonary epithelial cell maturation publication-title: Am. J. Physiol. Lung Cell. Mol. Physiol. – volume: 7 start-page: 6353 year: 2016 end-page: 6368 ident: bib9 article-title: Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer publication-title: Oncotarget – volume: 29 start-page: 1587 year: 2015 end-page: 1592 ident: bib23 article-title: Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis publication-title: Genes Dev. – volume: 13 start-page: 403 year: 2013 end-page: 418 ident: bib29 article-title: The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network publication-title: Cell Stem Cell – volume: 3 start-page: 227 year: 2011 end-page: 233 ident: bib35 article-title: E-Cadherin as a diagnostic biomarker in breast cancer publication-title: N. Am. J. Med. Sci. – volume: 25 start-page: 685 year: 2005 end-page: 698 ident: bib36 article-title: The transcription factor gene Nfib is essential for both lung maturation and brain development publication-title: Mol. Cell. Biol. – volume: 25 start-page: S18 year: 2012 end-page: S30 ident: bib38 article-title: Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas publication-title: Mod. Pathol. – volume: 156 start-page: 1298 year: 2014 end-page: 1311 ident: bib25 article-title: Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing publication-title: Cell – volume: 111 start-page: 14788 year: 2014 end-page: 14793 ident: bib2 article-title: ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers publication-title: Proc. Natl. Acad. Sci. USA – volume: 22 start-page: 208 year: 2012 end-page: 215 ident: bib8 article-title: Cell polarity proteins and cancer publication-title: Semin. Cancer Biol. – volume: 47 start-page: 490 year: 2008 end-page: 499 ident: bib14 article-title: DNA copy number alterations and expression of relevant genes in triple-negative breast cancer publication-title: Genes Chromosomes Cancer – volume: 495 start-page: 98 year: 2013 end-page: 102 ident: bib6 article-title: NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche publication-title: Nature – volume: 92 start-page: 423 year: 2001 end-page: 428 ident: bib42 article-title: A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB publication-title: Jpn. J. Cancer Res. – volume: 35 start-page: 2177 year: 2016 end-page: 2182 ident: bib1 article-title: Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland publication-title: Oncol. Rep. – volume: 4 start-page: 181 year: 2003 end-page: 189 ident: bib27 article-title: Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model publication-title: Cancer Cell – volume: 58 start-page: 741 year: 1989 end-page: 753 ident: bib26 article-title: The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain publication-title: Cell – volume: 44 start-page: 1111 year: 2012 end-page: 1116 ident: bib32 article-title: Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer publication-title: Nat. Genet. – volume: 5 start-page: 150 year: 2011 end-page: 155 ident: bib12 article-title: Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma publication-title: Mol. Oncol. – volume: 34 start-page: 99 year: 2007 end-page: 119 ident: bib16 article-title: Loss- and gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon publication-title: Mol. Cell. Neurosci. – volume: 37 start-page: 294 year: 2015 end-page: 304 ident: bib33 article-title: E-cadherin’s role in development, tissue homeostasis and disease: insights from mouse models: tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease publication-title: BioEssays – volume: 10 start-page: 553 year: 2015 end-page: 564 ident: bib10 article-title: The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung publication-title: J. Thorac. Oncol. – volume: 19 start-page: 244 year: 2011 end-page: 256 ident: bib4 article-title: A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer publication-title: Cancer Cell – volume: 25 start-page: 1470 year: 2011 end-page: 1475 ident: bib7 article-title: Nuclear factor I/B is an oncogene in small cell lung cancer publication-title: Genes Dev. – volume: 16 start-page: 49 year: 2015 ident: bib21 article-title: CopywriteR: DNA copy number detection from off-target sequence data publication-title: Genome Biol. – volume: 33 start-page: 1205 year: 2015 end-page: 1211 ident: bib31 article-title: Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: a retrospective study publication-title: J. Orthop. Res. – volume: 33 start-page: 1335 year: 2015 end-page: 1341 ident: bib43 article-title: p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB publication-title: Oncol. Rep. – volume: 52 start-page: 802 year: 2013 end-page: 816 ident: bib20 article-title: Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer publication-title: Genes Chromosomes Cancer – volume: 144 start-page: 27 year: 2011 end-page: 40 ident: bib37 article-title: Massive genomic rearrangement acquired in a single catastrophic event during cancer development publication-title: Cell – volume: 354 start-page: 242 year: 2011 end-page: 252 ident: bib17 article-title: Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation publication-title: Dev. Biol. – volume: 524 start-page: 47 year: 2015 end-page: 53 ident: bib11 article-title: Comprehensive genomic profiles of small cell lung cancer publication-title: Nature – volume: 121 start-page: 664 year: 2015 end-page: 672 ident: bib3 article-title: Small cell lung cancer: where do we go from here? publication-title: Cancer – volume: 10 start-page: 1755 year: 2015 end-page: 1785 ident: bib19 article-title: Using the GEMM-ESC strategy to study gene function in mouse models publication-title: Nat. Protoc. – volume: 33 start-page: 1205 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib31 article-title: Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: a retrospective study publication-title: J. Orthop. Res. doi: 10.1002/jor.22873 – volume: 524 start-page: 47 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib11 article-title: Comprehensive genomic profiles of small cell lung cancer publication-title: Nature doi: 10.1038/nature14664 – volume: 156 start-page: 1298 year: 2014 ident: 10.1016/j.celrep.2016.06.020_bib25 article-title: Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing publication-title: Cell doi: 10.1016/j.cell.2014.02.031 – volume: 10 start-page: 553 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib10 article-title: The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung publication-title: J. Thorac. Oncol. doi: 10.1097/JTO.0000000000000459 – volume: 272 start-page: 10739 year: 1997 ident: 10.1016/j.celrep.2016.06.020_bib24 article-title: NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.16.10739 – volume: 37 start-page: 294 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib33 article-title: E-cadherin’s role in development, tissue homeostasis and disease: insights from mouse models: tissue-specific inactivation of the adhesion protein E-cadherin in mice reveals its functions in health and disease publication-title: BioEssays doi: 10.1002/bies.201400141 – volume: 25 start-page: 1470 year: 2011 ident: 10.1016/j.celrep.2016.06.020_bib7 article-title: Nuclear factor I/B is an oncogene in small cell lung cancer publication-title: Genes Dev. doi: 10.1101/gad.2046711 – volume: 44 start-page: 1111 year: 2012 ident: 10.1016/j.celrep.2016.06.020_bib32 article-title: Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer publication-title: Nat. Genet. doi: 10.1038/ng.2405 – volume: 29 start-page: 1587 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib23 article-title: Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis publication-title: Genes Dev. doi: 10.1101/gad.262998.115 – volume: 3 start-page: 227 year: 2011 ident: 10.1016/j.celrep.2016.06.020_bib35 article-title: E-Cadherin as a diagnostic biomarker in breast cancer publication-title: N. Am. J. Med. Sci. doi: 10.4297/najms.2011.3227 – volume: 249 start-page: 31 year: 2000 ident: 10.1016/j.celrep.2016.06.020_bib13 article-title: Roles of the NFI/CTF gene family in transcription and development publication-title: Gene doi: 10.1016/S0378-1119(00)00140-2 – volume: 10 start-page: 1243 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib39 article-title: The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification publication-title: J. Thorac. Oncol. doi: 10.1097/JTO.0000000000000630 – volume: 35 start-page: 2177 year: 2016 ident: 10.1016/j.celrep.2016.06.020_bib1 article-title: Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland publication-title: Oncol. Rep. doi: 10.3892/or.2016.4621 – volume: 58 start-page: 741 year: 1989 ident: 10.1016/j.celrep.2016.06.020_bib26 article-title: The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain publication-title: Cell doi: 10.1016/0092-8674(89)90108-6 – volume: 33 start-page: 1335 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib43 article-title: p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB publication-title: Oncol. Rep. doi: 10.3892/or.2015.3715 – volume: 92 start-page: 423 year: 2001 ident: 10.1016/j.celrep.2016.06.020_bib42 article-title: A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB publication-title: Jpn. J. Cancer Res. doi: 10.1111/j.1349-7006.2001.tb01112.x – volume: 5 start-page: 150 year: 2011 ident: 10.1016/j.celrep.2016.06.020_bib12 article-title: Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma publication-title: Mol. Oncol. doi: 10.1016/j.molonc.2011.01.006 – volume: 16 start-page: 49 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib21 article-title: CopywriteR: DNA copy number detection from off-target sequence data publication-title: Genome Biol. doi: 10.1186/s13059-015-0617-1 – volume: 7 start-page: 6353 year: 2016 ident: 10.1016/j.celrep.2016.06.020_bib9 article-title: Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer publication-title: Oncotarget doi: 10.18632/oncotarget.7047 – volume: 34 start-page: 2921 year: 2014 ident: 10.1016/j.celrep.2016.06.020_bib30 article-title: NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2319-13.2014 – volume: 3 start-page: 741 year: 2014 ident: 10.1016/j.celrep.2016.06.020_bib40 article-title: MiR-153 targets the nuclear factor-1 family and protects against teratogenic effects of ethanol exposure in fetal neural stem cells publication-title: Biol. Open doi: 10.1242/bio.20147765 – volume: 6 start-page: 212 year: 2014 ident: 10.1016/j.celrep.2016.06.020_bib18 article-title: Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells publication-title: EMBO Mol. Med. doi: 10.1002/emmm.201303297 – volume: 7 start-page: 165 year: 2013 ident: 10.1016/j.celrep.2016.06.020_bib22 article-title: Mouse models for lung cancer publication-title: Mol. Oncol. doi: 10.1016/j.molonc.2013.02.010 – volume: 52 start-page: 802 year: 2013 ident: 10.1016/j.celrep.2016.06.020_bib20 article-title: Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.22076 – volume: 34 start-page: 99 year: 2007 ident: 10.1016/j.celrep.2016.06.020_bib16 article-title: Loss- and gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon publication-title: Mol. Cell. Neurosci. doi: 10.1016/j.mcn.2006.10.008 – volume: 47 start-page: 490 year: 2008 ident: 10.1016/j.celrep.2016.06.020_bib14 article-title: DNA copy number alterations and expression of relevant genes in triple-negative breast cancer publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20550 – volume: 4 start-page: 181 year: 2003 ident: 10.1016/j.celrep.2016.06.020_bib27 article-title: Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model publication-title: Cancer Cell doi: 10.1016/S1535-6108(03)00220-4 – volume: 144 start-page: 27 year: 2011 ident: 10.1016/j.celrep.2016.06.020_bib37 article-title: Massive genomic rearrangement acquired in a single catastrophic event during cancer development publication-title: Cell doi: 10.1016/j.cell.2010.11.055 – volume: 22 start-page: 208 year: 2012 ident: 10.1016/j.celrep.2016.06.020_bib8 article-title: Cell polarity proteins and cancer publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2012.02.012 – volume: 354 start-page: 242 year: 2011 ident: 10.1016/j.celrep.2016.06.020_bib17 article-title: Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation publication-title: Dev. Biol. doi: 10.1016/j.ydbio.2011.04.002 – volume: 29 start-page: 1447 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib34 article-title: Origins, genetic landscape, and emerging therapies of small cell lung cancer publication-title: Genes Dev. doi: 10.1101/gad.263145.115 – volume: 28 start-page: 671 year: 2013 ident: 10.1016/j.celrep.2016.06.020_bib28 article-title: MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone publication-title: Histol. Histopathol. – volume: 74 start-page: 5139 year: 2014 ident: 10.1016/j.celrep.2016.06.020_bib5 article-title: Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-3602 – volume: 13 start-page: 403 year: 2013 ident: 10.1016/j.celrep.2016.06.020_bib29 article-title: The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.07.002 – volume: 309 start-page: L400 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib41 article-title: miR-124 regulates fetal pulmonary epithelial cell maturation publication-title: Am. J. Physiol. Lung Cell. Mol. Physiol. doi: 10.1152/ajplung.00356.2014 – volume: 10 start-page: 1755 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib19 article-title: Using the GEMM-ESC strategy to study gene function in mouse models publication-title: Nat. Protoc. doi: 10.1038/nprot.2015.114 – volume: 111 start-page: 14788 year: 2014 ident: 10.1016/j.celrep.2016.06.020_bib2 article-title: ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1410419111 – volume: 121 start-page: 664 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib3 article-title: Small cell lung cancer: where do we go from here? publication-title: Cancer doi: 10.1002/cncr.29098 – volume: 25 start-page: 685 year: 2005 ident: 10.1016/j.celrep.2016.06.020_bib36 article-title: The transcription factor gene Nfib is essential for both lung maturation and brain development publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.25.2.685-698.2005 – volume: 244 start-page: 227 year: 2015 ident: 10.1016/j.celrep.2016.06.020_bib15 article-title: Nuclear factor one transcription factors: divergent functions in developmental versus adult stem cell populations publication-title: Dev. Dyn. doi: 10.1002/dvdy.24182 – volume: 19 start-page: 244 year: 2011 ident: 10.1016/j.celrep.2016.06.020_bib4 article-title: A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.12.021 – volume: 495 start-page: 98 year: 2013 ident: 10.1016/j.celrep.2016.06.020_bib6 article-title: NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche publication-title: Nature doi: 10.1038/nature11847 – volume: 25 start-page: S18 issue: Suppl 1 year: 2012 ident: 10.1016/j.celrep.2016.06.020_bib38 article-title: Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas publication-title: Mod. Pathol. doi: 10.1038/modpathol.2011.150 – reference: 21764851 - Genes Dev. 2011 Jul 15;25(14):1470-5 – reference: 25764026 - J Orthop Res. 2015 Aug;33(8):1205-11 – reference: 18314908 - Genes Chromosomes Cancer. 2008 Jun;47(6):490-9 – reference: 9099724 - J Biol Chem. 1997 Apr 18;272(16):10739-45 – reference: 22941189 - Nat Genet. 2012 Oct;44(10):1111-6 – reference: 23389444 - Nature. 2013 Mar 7;495(7439):98-102 – reference: 25336398 - Cancer. 2015 Mar 1;121(5):664-72 – reference: 25591821 - Oncol Rep. 2015 Mar;33(3):1335-41 – reference: 22465739 - Semin Cancer Biol. 2012 Jun;22(3):208-15 – reference: 25063196 - Biol Open. 2014 Jul 25;3(8):741-58 – reference: 23716474 - Genes Chromosomes Cancer. 2013 Sep;52(9):802-16 – reference: 25267614 - Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14788-93 – reference: 26840454 - Oncotarget. 2016 Feb 9;7(6):6353-68 – reference: 22214967 - Mod Pathol. 2012 Jan;25 Suppl 1:S18-30 – reference: 25082813 - Cancer Res. 2014 Sep 15;74(18):5139-51 – reference: 21324755 - Mol Oncol. 2011 Apr;5(2):150-5 – reference: 25887352 - Genome Biol. 2015 Feb 27;16:49 – reference: 11346465 - Jpn J Cancer Res. 2001 Apr;92(4):423-8 – reference: 26883388 - Oncol Rep. 2016 Apr;35(4):2177-82 – reference: 28449525 - J Thorac Dis. 2017 Mar;9(3):E295-E296 – reference: 24553933 - J Neurosci. 2014 Feb 19;34(8):2921-30 – reference: 26220992 - Genes Dev. 2015 Jul 15;29(14):1447-62 – reference: 23172052 - Histol Histopathol. 2013 May;28(5):671-8 – reference: 2504497 - Cell. 1989 Aug 25;58(4):741-53 – reference: 26168399 - Nature. 2015 Aug 6;524(7563):47-53 – reference: 25675280 - J Thorac Oncol. 2015 Apr;10(4):553-64 – reference: 21215367 - Cell. 2011 Jan 7;144(1):27-40 – reference: 14522252 - Cancer Cell. 2003 Sep;4(3):181-9 – reference: 21316603 - Cancer Cell. 2011 Feb 15;19(2):244-56 – reference: 22558599 - N Am J Med Sci. 2011 May;3(5):227-33 – reference: 26215568 - Genes Dev. 2015 Aug 1;29(15):1587-92 – reference: 26291008 - J Thorac Oncol. 2015 Sep;10(9):1243-60 – reference: 10831836 - Gene. 2000 May 16;249(1-2):31-45 – reference: 23933087 - Cell Stem Cell. 2013 Oct 3;13(4):403-18 – reference: 17158062 - Mol Cell Neurosci. 2007 Jan;34(1):99-119 – reference: 25156673 - Dev Dyn. 2015 Mar;244(3):227-38 – reference: 21513708 - Dev Biol. 2011 Jun 15;354(2):242-52 – reference: 26071557 - Am J Physiol Lung Cell Mol Physiol. 2015 Aug 15;309(4):L400-13 – reference: 24630729 - Cell. 2014 Mar 13;156(6):1298-311 – reference: 26492136 - Nat Protoc. 2015 Nov;10(11):1755-85 – reference: 15632069 - Mol Cell Biol. 2005 Jan;25(2):685-98 – reference: 25449798 - Bioessays. 2015 Mar;37(3):294-304 – reference: 24401838 - EMBO Mol Med. 2014 Feb;6(2):212-25 – reference: 23481268 - Mol Oncol. 2013 Apr;7(2):165-77 |
| SSID | ssj0000601194 |
| Score | 2.487832 |
| Snippet | Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor, and no effective treatment is available to date. Mouse models of SCLC based on the... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 631 |
| SubjectTerms | Animals Biomarkers, Tumor - metabolism Cadherins - metabolism Cell Proliferation - physiology Disease Models, Animal Disease Progression Gene Expression Regulation, Neoplastic - physiology Humans Lung Neoplasms - metabolism Lung Neoplasms - pathology Mice Neoplasm Metastasis - pathology NFI Transcription Factors - metabolism Proto-Oncogene Proteins c-myc - metabolism Retinoblastoma Protein - metabolism Small Cell Lung Carcinoma - metabolism Small Cell Lung Carcinoma - pathology Tumor Suppressor Protein p53 - metabolism |
| Title | Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients |
| URI | https://dx.doi.org/10.1016/j.celrep.2016.06.020 https://www.ncbi.nlm.nih.gov/pubmed/27373156 https://www.proquest.com/docview/1806436512 https://pubmed.ncbi.nlm.nih.gov/PMC4956617 https://doaj.org/article/0c5e4b5dae114c238369da8b5e06aff1 |
| Volume | 16 |
| WOSCitedRecordID | wos000380264200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBdb2WAvo_tO1xUN9mpmW7JlPa7pwgprCGyDvAl9mXmkzrDTQaF_fO8kOyTbQ172YoMtyz7pdPeTdfodIR-4qCzg_BqQm04TzrgGOwjjymmA47l3rChtSDYh5vNquZSLnVRfGBMW6YFjw31MbeG5KZz2gNwtOBhWSqcrU_i01HUdJj6pkDuTqWiDkcsMl5TzHGO2ci7GfXMhuMv6VeeRrjIrA30npvve8UuBvn_PPf0LP_-OotxxS7Nj8nTAk_RTlOMZeeDb5-RxzDB5-4LcBV80WgY6C9l16Hx2eU4ve6rpRYdxGXRd02_XerWiUw-Hr2AA6BTVoaMLjN-K3B20aekV2BWqW0dxj09Pr_xG45akxtKLuNKDhRaRq7V_SX7MPn-ffkmGhAuJLWSxSbgxjkmji9wDbnSuNEJWmRdOwFiyvOIchLVpnRVw4nDXSmec1tzV6O0Me0WO2nXr3xCaegAHtmRGi4zrVFYucyWrHVSHuT3chLCxuZUd2MgxKcZKjWFnv1TsJIWdpDD6Lk8nJNk-9TuycRwof449uS2LXNrhAmiYGjRMHdKwCRGjHqgBlkS4AVU1B17_flQbBaMWl2J069c3vcoqhIIloK0JeR3VaPuRACgFg2k1vHdPwfak2L_TNj8DMzjOdgGSnvwPsd-SJygK_sfO5Ck52nQ3_h15ZP9smr47Iw_FsjoLg-4eWqswlQ |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcription+Factor+NFIB+Is+a+Driver+of+Small+Cell+Lung+Cancer+Progression+in+Mice+and+Marks+Metastatic+Disease+in+Patients&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Ekaterina%C2%A0A.+Semenova&rft.au=Min-chul+Kwon&rft.au=Kim+Monkhorst&rft.au=Ji-Ying+Song&rft.date=2016-07-19&rft.pub=Elsevier&rft.issn=2211-1247&rft.eissn=2211-1247&rft.volume=16&rft.issue=3&rft.spage=631&rft.epage=643&rft_id=info:doi/10.1016%2Fj.celrep.2016.06.020&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_0c5e4b5dae114c238369da8b5e06aff1 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-1247&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-1247&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-1247&client=summon |